EtoposideDrug Screening Assays, AntitumorAntineoplastic Agents, PhytogenicAntineoplastic AgentsXenograft Model Antitumor AssaysAntineoplastic Combined Chemotherapy ProtocolsTopoisomerase II InhibitorsCisplatinCell Line, TumorDoxorubicinIfosfamideCarcinoma, Small CellDNA Topoisomerases, Type IIAntibiotics, AntineoplasticPodophyllotoxinTumor Cells, CulturedLeukemia P388CyclophosphamideVincristineLung NeoplasmsApoptosisDose-Response Relationship, DrugAmsacrineDrug Administration ScheduleMice, NudeMolecular StructureCarboplatinNeoplasmsNeoplasms, ExperimentalCombined Modality TherapyNeoplasm TransplantationDrug SynergismBleomycinSarcoma 180Cell SurvivalInhibitory Concentration 50Melanoma, ExperimentalDrug Resistance, NeoplasmStructure-Activity RelationshipMice, Inbred BALB CLeukemia L1210CytarabineAdministration, OralOrganophosphorus CompoundsTeniposideCamptothecinDrug Evaluation, PreclinicalTopoisomerase I InhibitorsGerminomaCancer VaccinesCell ProliferationSulfur CompoundsTreatment OutcomeAntigens, NeoplasmEnzyme InhibitorsTopoisomerase InhibitorsMice, Inbred C57BLDNA DamageLeukopeniaPaclitaxelMitoxantroneInfusions, IntravenousNucleic Acid Synthesis InhibitorsImmunotherapyTopotecanPlant ExtractsVolatile Organic CompoundsTime FactorsRemission InductionTransplantation, AutologousDrug EvaluationDrug ResistanceProdrugsCarmustineChromatography, High Pressure LiquidTesticular NeoplasmsMagnetic Resonance SpectroscopyCell LineDrug Resistance, MultipleMice, SCIDTransplantation, HeterologousSurvival AnalysisP-GlycoproteinRazoxaneCell DivisionHL-60 CellsSurvival RateCell CycleHodgkin DiseaseNeoplasms, Germ Cell and EmbryonalImmunotherapy, AdoptiveVinblastineLymphoma, Non-HodgkinDisease-Free SurvivalEllipticinesEnediynesHematologic DiseasesAntineoplastic Agents, AlkylatingFlow CytometryColonic Neoplasms